Analyst consensus rating
Anavex Life Sciences Analyst Rating: none
Direct answer
Anavex Life Sciences's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $20.00.
Forecast evidence checked September 17, 2026.
Get free Anavex Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.36
- Average price target
- $20.00
- High price target
- $20.00
- Low price target
- $20.00
- Low target gap
- +747.5%
- Target upside
- +747.5%
- High target gap
- +747.5%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- September 17, 2026
- Valid through
- September 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Anavex Life Sciences?
Anavex Life Sciences has a verified none consensus. The same dataset has an average price target of $20.00.
How far are Anavex Life Sciences's low and high targets from the recorded price?
The low target implies +747.5%, while the high target implies +747.5%.
How many analysts are included in Anavex Life Sciences's consensus?
The verified consensus includes 1 analysts.
How is Anavex Life Sciences's target upside or downside calculated?
The average target of $20.00 is divided by the recorded price of $2.36, then one is subtracted to produce +747.5%. This does not guarantee a future return.
When was Anavex Life Sciences's analyst forecast verified?
The data was verified on 2026-09-17. The dataset is valid through 2026-09-24.